Eryseng Injection 25 Dose

Target species Pigs. Indications for use For the active immunisation of male and female pigs to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by Erysipelothrix rhusiopathiae, serotype 1 and serotype 2. Onset of immunity: three weeks after completion of the basic vaccination scheme. Duration of immunity: six months. Contra-indications Do not use in case of hypersensitivity to the active substance, to the adjuvants or to any of the excipients. Special warnings for each target species None. Special precautions for use Vaccinate only healthy animals. Special precautions to be taken by the person administering the veterinary medicinal product to animals In case of adverse reactions following accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. Adverse reactions (frequency and seriousness) Very common adverse reactions: - Mild to moderate inflammation at the injection site that typically resolves within four days but in some cases may persist for up to 12 days post-vaccination. Common adverse reactions: - A transient increase in body temperature within the first 6 hours after vaccination, which spontaneously resolves within 24 hours. Very rare adverse reactions: Anaphylactic-type reactions have been reported in spontaneous reports and appropriate symptomatictreatment is recommended The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment). - common (more than 1 but less than 10 animals in 100 animals). - uncommon (more than 1 but less than 10 animals in 1,000 animals). - rare (more than 1 but less than 10 animals in 10,000 animals). - very rare (less than 1 animal in 10,000 animals, including isolated reports). Use during pregnancy, lactation or lay Can be used during pregnancy and lacatation. Interactions No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Vat Rate: 20%